Cargando…
Depot Medroxyprogesterone Acetate Use and Blood Lead Levels in a Cohort of Young Women
BACKGROUND: Injectable contraceptive use is common, with 74 million users worldwide. Use of the injectable contraceptive depot medroxyprogesterone acetate (DMPA) is associated with bone mineral density loss. We hypothesize that increased bone resorption with DMPA use allows for mobilization of the t...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Environmental Health Perspectives
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673223/ https://www.ncbi.nlm.nih.gov/pubmed/33206002 http://dx.doi.org/10.1289/EHP7017 |
_version_ | 1783611281298685952 |
---|---|
author | Upson, Kristen Harmon, Quaker E. Heffron, Renee Hall, Janet E. Wise, Lauren A. Wegienka, Ganesa Tokar, Erik J. Baird, Donna D. |
author_facet | Upson, Kristen Harmon, Quaker E. Heffron, Renee Hall, Janet E. Wise, Lauren A. Wegienka, Ganesa Tokar, Erik J. Baird, Donna D. |
author_sort | Upson, Kristen |
collection | PubMed |
description | BACKGROUND: Injectable contraceptive use is common, with 74 million users worldwide. Use of the injectable contraceptive depot medroxyprogesterone acetate (DMPA) is associated with bone mineral density loss. We hypothesize that increased bone resorption with DMPA use allows for mobilization of the toxic metal lead stored in bone to blood, presenting users with increased systemic exposure to lead. OBJECTIVE: The objective of our study was to investigate the association between current DMPA use and blood lead concentrations. METHODS: We conducted a cross-sectional analysis using enrollment data from the Study of Environment, Lifestyle & Fibroids (SELF), a cohort of 1,693 African-American women who were 23–35 years of age. Data on DMPA use were collected by computer-assisted telephone interview. Blood lead concentrations were measured in whole blood samples among 1,548 participants (91% of cohort). We estimated the adjusted percent difference in blood lead concentrations and 95% confidence intervals (CI) between current DMPA users and nonusers using multivariable linear regression. RESULTS: Geometric mean blood lead concentration was [Formula: see text] (95% CI: 0.67, 0.71). After adjustment, current DMPA users (7% of cohort) had blood lead concentrations that were 18% higher than those of nonusers (95% CI: 8%, 29%). Similar associations were observed with additional analyses to assess for potential bias from smoking, DMPA-induced amenorrhea, use of estrogen-containing contraceptives, having given birth in the prior year, and history of medical conditions or current medication use associated with bone loss. DISCUSSION: Our results indicate that current DMPA use is associated with increased blood lead concentrations. Further research, particularly in populations highly exposed to lead, is warranted to consider tradeoffs between the adverse effects of lead on human health and the importance of DMPA as a contraceptive option to prevent unintended pregnancy. https://doi.org/10.1289/EHP7017 |
format | Online Article Text |
id | pubmed-7673223 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Environmental Health Perspectives |
record_format | MEDLINE/PubMed |
spelling | pubmed-76732232020-11-20 Depot Medroxyprogesterone Acetate Use and Blood Lead Levels in a Cohort of Young Women Upson, Kristen Harmon, Quaker E. Heffron, Renee Hall, Janet E. Wise, Lauren A. Wegienka, Ganesa Tokar, Erik J. Baird, Donna D. Environ Health Perspect Research BACKGROUND: Injectable contraceptive use is common, with 74 million users worldwide. Use of the injectable contraceptive depot medroxyprogesterone acetate (DMPA) is associated with bone mineral density loss. We hypothesize that increased bone resorption with DMPA use allows for mobilization of the toxic metal lead stored in bone to blood, presenting users with increased systemic exposure to lead. OBJECTIVE: The objective of our study was to investigate the association between current DMPA use and blood lead concentrations. METHODS: We conducted a cross-sectional analysis using enrollment data from the Study of Environment, Lifestyle & Fibroids (SELF), a cohort of 1,693 African-American women who were 23–35 years of age. Data on DMPA use were collected by computer-assisted telephone interview. Blood lead concentrations were measured in whole blood samples among 1,548 participants (91% of cohort). We estimated the adjusted percent difference in blood lead concentrations and 95% confidence intervals (CI) between current DMPA users and nonusers using multivariable linear regression. RESULTS: Geometric mean blood lead concentration was [Formula: see text] (95% CI: 0.67, 0.71). After adjustment, current DMPA users (7% of cohort) had blood lead concentrations that were 18% higher than those of nonusers (95% CI: 8%, 29%). Similar associations were observed with additional analyses to assess for potential bias from smoking, DMPA-induced amenorrhea, use of estrogen-containing contraceptives, having given birth in the prior year, and history of medical conditions or current medication use associated with bone loss. DISCUSSION: Our results indicate that current DMPA use is associated with increased blood lead concentrations. Further research, particularly in populations highly exposed to lead, is warranted to consider tradeoffs between the adverse effects of lead on human health and the importance of DMPA as a contraceptive option to prevent unintended pregnancy. https://doi.org/10.1289/EHP7017 Environmental Health Perspectives 2020-11-18 /pmc/articles/PMC7673223/ /pubmed/33206002 http://dx.doi.org/10.1289/EHP7017 Text en https://ehp.niehs.nih.gov/about-ehp/license EHP is an open-access journal published with support from the National Institute of Environmental Health Sciences, National Institutes of Health. All content is public domain unless otherwise noted. |
spellingShingle | Research Upson, Kristen Harmon, Quaker E. Heffron, Renee Hall, Janet E. Wise, Lauren A. Wegienka, Ganesa Tokar, Erik J. Baird, Donna D. Depot Medroxyprogesterone Acetate Use and Blood Lead Levels in a Cohort of Young Women |
title | Depot Medroxyprogesterone Acetate Use and Blood Lead Levels in a Cohort of Young Women |
title_full | Depot Medroxyprogesterone Acetate Use and Blood Lead Levels in a Cohort of Young Women |
title_fullStr | Depot Medroxyprogesterone Acetate Use and Blood Lead Levels in a Cohort of Young Women |
title_full_unstemmed | Depot Medroxyprogesterone Acetate Use and Blood Lead Levels in a Cohort of Young Women |
title_short | Depot Medroxyprogesterone Acetate Use and Blood Lead Levels in a Cohort of Young Women |
title_sort | depot medroxyprogesterone acetate use and blood lead levels in a cohort of young women |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673223/ https://www.ncbi.nlm.nih.gov/pubmed/33206002 http://dx.doi.org/10.1289/EHP7017 |
work_keys_str_mv | AT upsonkristen depotmedroxyprogesteroneacetateuseandbloodleadlevelsinacohortofyoungwomen AT harmonquakere depotmedroxyprogesteroneacetateuseandbloodleadlevelsinacohortofyoungwomen AT heffronrenee depotmedroxyprogesteroneacetateuseandbloodleadlevelsinacohortofyoungwomen AT halljanete depotmedroxyprogesteroneacetateuseandbloodleadlevelsinacohortofyoungwomen AT wiselaurena depotmedroxyprogesteroneacetateuseandbloodleadlevelsinacohortofyoungwomen AT wegienkaganesa depotmedroxyprogesteroneacetateuseandbloodleadlevelsinacohortofyoungwomen AT tokarerikj depotmedroxyprogesteroneacetateuseandbloodleadlevelsinacohortofyoungwomen AT bairddonnad depotmedroxyprogesteroneacetateuseandbloodleadlevelsinacohortofyoungwomen |